Low‐dose gemcitabine plus nab‐paclitaxel <i>versus</i> standard‐dose gemcitabine plus nab‐paclitaxel in elderly patients with metastatic pancreatic cancer: A randomized Phase <scp>II</scp> trial
Article 2023 en
Authors
HI
Hajime Imai
HM
Hisakazu Matsumoto
YY
Yukitaka Yamashita
Abstract
1 min read
Low-dose GnP had an equivalent efficacy to conventional therapy; however, it did not reduce adverse events.
Meletios A Dimopoulos, Katja Weisel, Niels W.C.J. van de Donk, Karthik Ramasamy, Barbara Gamberi, Matthew Streetly, Massimo Offidani, Frank Bridoux, Javier de la Rubia, María‐Victoria Mateos, Antonio Ardizzoia, Elisabeth Kueenburg, Shona Collins, Antonia Di Micco, Barbara Rosettani, Yan Li, Pamela Bacon, Pieter Sonneveld
Discussion(0)
No comments yet. Be the first to comment.